Biolase (BIOL) Reports Q4 EPS of ($0.03)

Biolase (NASDAQ: BIOL) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $11.97 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
• Netskope, Inc. (NTSK) Tops Q1 EPS by 1c, Offers Guidance